FCRL4

 

Full name: Fc receptor like 4 Alias Symbol: FCRH4|IRTA1|IGFP2|CD307d
Type: protein-coding gene Cytoband: 1q23.1
Entrez ID: 83417 HGNC ID: HGNC:18507 Ensembl Gene: ENSG00000163518 OMIM ID: 605876
Drug and gene relationship at DGIdb

 

Expression of FCRL4:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 FCRL4 83417 224403_at -0.1566 0.7306
GSE26886 FCRL4 83417 224403_at 0.1850 0.4937
GSE45670 FCRL4 83417 224403_at 0.0668 0.6930
GSE53622 FCRL4 83417 35048 -0.0305 0.7744
GSE53624 FCRL4 83417 35048 -0.6649 0.0000
GSE63941 FCRL4 83417 224401_s_at -0.0838 0.4595
GSE77861 FCRL4 83417 224403_at -0.1040 0.2564
GSE97050 FCRL4 83417 A_23_P115200 0.3921 0.2515
TCGA FCRL4 83417 RNAseq 0.2712 0.7443

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by FCRL4 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of FCRL4:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 FCRL4 83417 9 1 20
GSE20123 FCRL4 83417 9 0 21
GSE43470 FCRL4 83417 7 2 34
GSE46452 FCRL4 83417 2 1 56
GSE47630 FCRL4 83417 14 0 26
GSE54993 FCRL4 83417 0 5 65
GSE54994 FCRL4 83417 16 0 37
GSE60625 FCRL4 83417 0 0 11
GSE74703 FCRL4 83417 7 2 27
GSE74704 FCRL4 83417 4 0 16
TCGA FCRL4 83417 39 2 55

Total number of gains: 107; Total number of losses: 13; Total Number of normals: 368.  


 

Somatic mutations of FCRL4:

 

Generating mutation plots.

 

Highly correlated genes for FCRL4:

 

Showing top 20/86 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
FCRL4RARRES10.696382303
FCRL4FLT3LG0.694568303
FCRL4AMPD10.69452303
FCRL4EXOC3L40.682447303
FCRL4ABCB40.679697404
FCRL4CEP1280.666435303
FCRL4CHRM10.665985303
FCRL4GRAP20.662117303
FCRL4FCRL30.660083504
FCRL4C16orf540.655022404
FCRL4CD190.655015606
FCRL4OGFRL10.651518303
FCRL4KCNE30.646672303
FCRL4PTPN220.642584303
FCRL4FCRLA0.641097605
FCRL4DOK10.635694303
FCRL4CCL280.628768403
FCRL4RAB39B0.623608403
FCRL4METTL60.62144404
FCRL4KCNA30.620438403

For details and further investigation, click here